Physician profile
Luis E Carrillo
NPI 1821092370
$5,157.89
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $4,393 · 2021: $88.30 · 2022: $226 · 2023: $17.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,027.78 | 2020 | |
| Boston Scientific Corporation | $499.22 | 2019-2021 | |
| Endologix LLC | $131.20 | 2019 | |
| Merck Sharp & Dohme LLC | $71.79 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $65.49 | 2019-2022 | |
| Abbott Laboratories | $65.30 | 2019-2023 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.73 | 2020-2022 | |
| Medtronic, INC. | $42.30 | 2021-2022 | |
| Biosense Webster, INC. | $38.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $34.94 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.57 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.23 | 2019 | |
| Philips North America LLC | $19.64 | 2020 | |
| Surmodics, INC. | $18.08 | 2022 | |
| Pfizer INC. | $15.90 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Carrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.